| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1002/14651858.CD004544.PUB2 |
| P953 | full work available at URL | http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004544.pub2/fullpdf |
| https://doi.org/10.1002/14651858.cd004544.pub2 | ||
| https://europepmc.org/articles/PMC11382336 | ||
| https://europepmc.org/articles/PMC11382336?pdf=render | ||
| P3181 | OpenCitations bibliographic resource ID | 2172634 |
| P932 | PMC publication ID | 11382336 |
| P698 | PubMed publication ID | 22895942 |
| P50 | author | Lise L Gluud | Q52353956 |
| Aleksander Krag | Q56849497 | ||
| P2860 | cites work | Endoscopic therapy or beta-blockers for primary prevention of bleeding oesophageal varices | Q24247564 |
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Sequential methods for random-effects meta-analysis | Q24289522 | ||
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial | Q28185754 | ||
| Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study | Q28335352 | ||
| Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial | Q28373295 | ||
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
| Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches | Q33201947 | ||
| Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review | Q33263463 | ||
| Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
| Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosis | Q33961964 | ||
| The critically ill liver patient: the variceal bleeder | Q34180406 | ||
| Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy | Q34396567 | ||
| Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding | Q34508947 | ||
| Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial | Q34510409 | ||
| Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding | Q34517607 | ||
| A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. | Q34527881 | ||
| Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis | Q58622872 | ||
| Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. The Study Group of Primary Prophylaxis | Q68046451 | ||
| Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study | Q68125129 | ||
| Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo | Q68631172 | ||
| Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group | Q70150651 | ||
| Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis | Q70681115 | ||
| Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP) | Q71916832 | ||
| Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding | Q73233281 | ||
| A prospective, randomized comparison of the ease and safety of variceal ligation using a multiband vs. a conventional ligation device | Q73370917 | ||
| Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding | Q74659528 | ||
| Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study | Q77983739 | ||
| Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999 | Q81491567 | ||
| Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation | Q81835679 | ||
| Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis | Q82853308 | ||
| Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial | Q34555329 | ||
| Prevention of variceal rebleeding | Q35089529 | ||
| Variable use of endoscopic haemostasis in the management of bleeding peptic ulcers | Q35514470 | ||
| Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding | Q36041168 | ||
| Complications of portal hypertension in adults: a French consensus | Q36065546 | ||
| Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients | Q36178972 | ||
| Bias in clinical intervention research. | Q36380552 | ||
| Outcome of non-variceal acute upper gastrointestinal bleeding in relation to the time of endoscopy and the experience of the endoscopist: a two-year survey | Q36496813 | ||
| Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials | Q37016175 | ||
| Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses | Q37138228 | ||
| Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals | Q39834471 | ||
| Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial | Q42010275 | ||
| Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices | Q42212698 | ||
| Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. | Q43024154 | ||
| Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage | Q43560935 | ||
| A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. | Q43574971 | ||
| Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding | Q43684444 | ||
| Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? | Q43707230 | ||
| Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers | Q43770467 | ||
| Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial | Q43928901 | ||
| Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites | Q44100198 | ||
| Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. | Q44113952 | ||
| Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. | Q44116670 | ||
| Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. | Q44458153 | ||
| Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis | Q44539376 | ||
| Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis | Q44784133 | ||
| Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial | Q44846113 | ||
| Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial | Q44921246 | ||
| Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis | Q44967731 | ||
| A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates | Q45297712 | ||
| Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. | Q45927000 | ||
| Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding | Q46397568 | ||
| Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices | Q46433686 | ||
| Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial | Q46691659 | ||
| Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe? | Q46865812 | ||
| Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis | Q46970294 | ||
| The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study | Q47597095 | ||
| Quality of reporting of noninferiority and equivalence randomized trials | Q53000120 | ||
| Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis | Q57792091 | ||
| Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension | Q58034591 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | varicose veins | Q201180 |
| prevention | Q1717246 | ||
| P304 | page(s) | CD004544 | |
| P577 | publication date | 2012-08-15 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults |
| Q90253521 | Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis |
| Q94334996 | Banding ligation versus no intervention for primary prevention in adults with oesophageal varices |
| Q24187759 | Banding ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children |
| Q89624112 | Beta-blockers in cirrhosis: Evidence-based indications and limitations |
| Q24193014 | Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis |
| Q61807656 | Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis |
| Q92644287 | Carvedilol vs endoscopic variceal ligation for primary and secondary prevention of variceal bleeding: Systematic review and meta-analysis |
| Q38223366 | Comorbidity in cirrhosis |
| Q37045749 | Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib. |
| Q48219904 | Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding. |
| Q90092409 | Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding |
| Q24187969 | Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension |
| Q38256338 | Endoscopic treatment of esophageal varices in patients with liver cirrhosis |
| Q35580226 | Factors impacting physicians' decisions to prevent variceal hemorrhage |
| Q36241702 | Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy |
| Q38874220 | Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension |
| Q24186697 | Interventions for managing advanced liver disease in cystic fibrosis |
| Q90752800 | Interventions for preventing and managing advanced liver disease in cystic fibrosis |
| Q38604015 | Interventions for preventing and managing advanced liver disease in cystic fibrosis. |
| Q36890029 | Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China |
| Q38227316 | Management of variceal hemorrhage: current concepts. |
| Q38094881 | Management of varices in patients with cirrhosis |
| Q55278061 | Managing portal hypertension in patients with liver cirrhosis. |
| Q38772074 | Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function |
| Q50054841 | Pharmacologic prevention of variceal bleeding and rebleeding |
| Q38690661 | Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. |
| Q37102443 | Portal hypertension and gastrointestinal bleeding: Diagnosis, prevention and management |
| Q49717262 | Prevention and management of gastroesophageal varices. |
| Q38229031 | Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis |
| Q94397632 | Primary prevention of bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis |
| Q26852622 | Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding |
| Q87681102 | Primary prophylaxis of variceal bleeding |
| Q26751239 | Quality of Care in the Cirrhotic Patient |
| Q33647530 | Recent advances in the management of variceal bleeding |
| Q58724975 | Removal of Esophageal Variceal Bands to Salvage Complete Esophageal Obstruction |
| Q28069136 | Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension |
| Q38327883 | Role of endoscopy in management of gastrointestinal complications of portal hypertension |
| Q24187719 | Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children |
| Q90058438 | Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis |
| Q94398275 | Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis |
| Q64244170 | Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial) |
| Q90580878 | The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis |
| Q89052821 | The Role of Therapeutic Endoscopy in Patients With Cirrhosis-Related Causes of Gastrointestinal Bleeding |
| Q93141080 | The adult survivor with variceal bleeding |
| Q34339621 | The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding |
| Q50052542 | Traditional and cumulative meta-analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma |
| Q94401268 | Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis |
| Q36374829 | U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. |
| Q94340226 | UEG Week 2016 Poster Presentations |
| Q61446100 | Update on the management of gastrointestinal varices |
Search more.